Skip to main content

Neuralink opens enrollment for its first human BCI implants

Elon Musk's Neuralink company, purveyors of the experimental N1 brain-computer interface (BCI), announced on Tuesday that it has finally opened enrollment for its first in-human study, dubbed Precise Robotically Implanted Brain-Computer Interface (PRIME, not PRIBCI). The announcement comes nearly a year after the company's most recent "show and tell" event, four months beyond the timeframe Musk had declared the trials would start, and nearly a month after rival Synchron had already beaten them to market.

Per the company's announcement, the PRIME study "aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for enabling people with paralysis to control external devices with their thoughts." As such, this study is looking primarily for "those who have quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS)," despite Musk's repeated and unfounded claims that the technology will be useful as vehicle for transhumanistic applications like learning Kung Fu from an SD card, uploading your consciousness to the web and controlling various household electronics with your mind.

Actually, that last one is a real goal of both the company and the technology. BCIs operate as a bridge between the human mind and machines, converting the analog electrical signals of our brains into digital signals that machines understand. The N1 system from Nueralink leverages a high-fidelity Utah Array of hair-thin probes that, unlike Synchron's Stentrode, must be installed via robotic keyhole surgery (performed by Nerualink's sewing machine-like R1 robot surgeon). This array will be fitted onto the patient's motor cortex where it will record and wirelessly transmit electrical impulses produced by the region to an associated app which will interpret them into actionable commands for the computer. "The initial goal of our BCI is to grant people the ability to control a computer cursor or keyboard using their thoughts alone," the release reads.

Neuralink has been working on the N1 system since 2017, one of the first companies in the industry to begin publicly developing a commercial BCI. However, Neuralink's efforts were waylaid last year after the company was credibly accused of causing the needless suffering and death of dozens of animal test subjects, which led to both a USDA investigation on animal cruelty charges and instigated the FDA to deny the company's request to fasttrack human trials. The PRIME study is being conducted under the auspices of the investigational device exemption (IDE), which the FDA awarded Neuralink this past May.   

This article originally appeared on Engadget at https://ift.tt/x0Ez7Wu

from Engadget is a web magazine with obsessive daily coverage of everything new in gadgets and consumer electronics https://ift.tt/x0Ez7Wu
via IFTTT

Comments

Popular posts from this blog

Instagram accidentally reinstated Pornhub’s banned account

After years of on-and-off temporary suspensions, Instagram permanently banned Pornhub’s account in September. Then, for a short period of time this weekend, the account was reinstated. By Tuesday, it was permanently banned again. “This was done in error,” an Instagram spokesperson told TechCrunch. “As we’ve said previously, we permanently disabled this Instagram account for repeatedly violating our policies.” Instagram’s content guidelines prohibit  nudity and sexual solicitation . A Pornhub spokesperson told TechCrunch, though, that they believe the adult streaming platform’s account did not violate any guidelines. Instagram has not commented on the exact reasoning for the ban, or which policies the account violated. It’s worrying from a moderation perspective if a permanently banned Instagram account can accidentally get switched back on. Pornhub told TechCrunch that its account even received a notice from Instagram, stating that its ban had been a mistake (that message itself w

Colorado police identified the serial killer who murdered 4 women 40 years ago after exhuming his body to analyze a DNA sample

A scientist examines computer images of DNA models. Getty Images Police in Colorado have cracked the cold cases of four women killed 40 years ago. Denver PD said genetic genealogy and DNA analysis helped them identify the serial killer. He had died by suicide in jail in 1981. DNA from his exhumed body matched evidence from the murders. Police in Colorado have cracked the code on four murder cases that went unsolved for 40 years, using DNA from the killer's exhumed body. The cases pertain to four women killed in the Denver metro area between 1978 and 1981. They were 33-year-old Madeleine Furey-Livaudais, 53-year-old Dolores Barajas, 27-year-old Gwendolyn Harris, and 17-year-old Antoinette Parks. The four women were stabbed to death. Denver Police Commander Matt Clark said in a press conference Friday that there was an "underlying sexual component" to the murders but didn't elaborate further. In 2009, a detective reviewed Parks' case and picked several p

Axeleo Capital raises $51 million fund

Axeleo Capital has raised a $51 million fund (€45 million). Axeleo first started with an accelerator focused on enterprise startups. The firm is now all grown up with an acceleration program and a full-fledged VC fund. The accelerator is now called Axeleo Scale , while the fund is called Axeleo Capital . And it’s important to mention both parts of the business as they work hand in hand. Axeleo picks up around 10 startups per year and help them reach the Series A stage. If they’re doing well over the 12 to 18 months of the program, Axeleo funds those startups using its VC fund. Limited partners behind the company’s first fund include Bpifrance through the French Tech Accélération program, the Auvergne-Rhône-Alpes region, Vinci Energies, Crédit Agricole, BNP Paribas, Caisse d’Épargne Rhône-Alpes as well as various business angels and family offices. The firm is also partnering with Hi Inov, the holding company of the Dentressangle family. Axeleo will take care of the early stage in